- Home
- COHR vs NBIX Comparison
COHR vs NBIX Comparison
Compare COHR & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COHR
- NBIX
- Stock Information
- Founded
- COHR 1971
- NBIX 1992
- Country
- COHR United States
- NBIX United States
- Employees
- COHR N/A
- NBIX N/A
- Industry
- COHR Electronic Components
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- COHR Technology
- NBIX Health Care
- Exchange
- COHR Nasdaq
- NBIX Nasdaq
- Market Cap
- COHR 14.5B
- NBIX 14.1B
- IPO Year
- COHR 1987
- NBIX 1996
- Fundamental
- Price
- COHR $104.43
- NBIX $140.90
- Analyst Decision
- COHR Strong Buy
- NBIX Strong Buy
- Analyst Count
- COHR 16
- NBIX 18
- Target Price
- COHR $109.40
- NBIX $161.50
- AVG Volume (30 Days)
- COHR 4.0M
- NBIX 709.1K
- Earning Date
- COHR 11-05-2025
- NBIX 10-29-2025
- Dividend Yield
- COHR N/A
- NBIX N/A
- EPS Growth
- COHR N/A
- NBIX 2.97
- EPS
- COHR N/A
- NBIX 3.39
- Revenue
- COHR $5,810,115,000.00
- NBIX $2,509,900,000.00
- Revenue This Year
- COHR $10.57
- NBIX $20.66
- Revenue Next Year
- COHR $7.08
- NBIX $14.64
- P/E Ratio
- COHR N/A
- NBIX $41.30
- Revenue Growth
- COHR 23.42
- NBIX 18.42
- 52 Week Low
- COHR $45.58
- NBIX $84.23
- 52 Week High
- COHR $123.25
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- COHR 59.60
- NBIX 56.42
- Support Level
- COHR $101.20
- NBIX $140.56
- Resistance Level
- COHR $108.05
- NBIX $144.04
- Average True Range (ATR)
- COHR 4.16
- NBIX 3.56
- MACD
- COHR 1.56
- NBIX -0.16
- Stochastic Oscillator
- COHR 83.63
- NBIX 51.96
About COHR Coherent Corp.
Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.